• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Clinical and epidemiological links with calcinosis in adult dermatomyositis

byHarrison NguyenandAdam Whittington
June 4, 2014
in Chronic Disease, Dermatology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In adults with dermatomyositis (DM), calcinosis was positively associated with longer disease duration, fingertip ulcers, and NXP-2 autoantibodies and was negatively associated with anti-TIF-1-g antibodies.

Evidence Rating Level: 2 (Good)

Study Rundown: DM is an autoimmune disease that occasionally involves calcinosis, a sign that results from calcium deposition in the skin and subcutaneous tissues. Several candidate autoantibodies have been associated with DM, though their relationship with calcinosis is poorly understood. In this study, the authors retrospectively analyzed DM from one referral center with the objective of identifying features that associate with calcinosis. After adjusting for confounding variables, authors identified several risk factors including fingertip ulcers, longer duration of disease, and NXP-2 autoantibodies that positively associated with calcinosis. Conversely, the presence of anti-TIF-1- antibodies were found to be protective. Also, the novel finding that calcinosis frequently co-occurs with fingertip ulcers led the authors to hypothesize that a vasculopathy-type process may be common to both pathogeneses. One of the strengths of this study was its large, well-phenotyped cohort that may be difficult to obtain for rare, complex diseases. A key weakness was a potential sampling bias, as only patients from a single tertiary clinic were studied.

Click to read the study in JAMA Dermatology

Relevant reading: Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?

In-Depth [retrospective cohort]: A total of 126 adult patients from Stanford University Medical Center were screened for a diagnosis of DM from 2006-2013. Of this group, 14 patients (11.1%) were reported to have developed calcinosis. Participants’ medical information was obtained and their plasma was screened for DM-specific and DM-associated autoantibodies using various protein assays. The data were evaluated using univariate and multivariate models and were adjusted for potential confounders. When compared to DM patients without calcinosis, analyses suggested that individuals with calcinosis had longer median disease duration (6.9 years [2.4-18.1] vs. 3.9[0.2-19.2]; p=.003), had more fingertip ulcers (50.0% vs. 9.3%, p<0.001), were more likely to have autoantibodies against NXP-2 (OR, 15.52; 95% CI, 2.0-119.9, p=.009), and were less likely to have anti-TIF-1-g antibodies (OR, 0.2; 95% CI, 0.01-0.99; p=.04). Other antibodies (anti-MDA-5 and anti-Ro-52) were initially identified as positive associations with calcinosis; however, the association wasn’t persistent after separate multivariate models for each antibody were examined.

Image: CC/Wiki

RELATED REPORTS

Intravenous immune globulin improved disease severity in dermatomyositis

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: dermatomyositis
Previous Post

Azithromycin linked with decreased mortality in elderly pneumonia patients

Next Post

Smaller changes in kidney filtration may predict end stage renal disease progression

RelatedReports

dermatomyositis
Chronic Disease

Intravenous immune globulin improved disease severity in dermatomyositis

October 10, 2022
Next Post
Urinary mRNA profiling accurately diagnoses rejection in kidney allografts

Smaller changes in kidney filtration may predict end stage renal disease progression

Diffusion tensor imaging valuable in the evaluation of peripheral neuropathy

Schizophrenia linked with higher rates of violence, suicide, and early mortality

Weekly dalbavancin noninferior to daily therapy for acute skin infection [DISCOVER 1 and 2 Trials]

Weekly dalbavancin noninferior to daily therapy for acute skin infection [DISCOVER 1 and 2 Trials]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transcarotid artery revascularization not associated with a significant difference in 30-day risk of stroke, death and myocardial infarction compared to carotid endarterectomy
  • Drinking characteristics in adolescence predict alcohol behaviors in early adulthood
  • Sodium-glucose co-transporter-2 inhibitors may decrease risk of in-stent thrombosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options